Abbott buys Solvay Luthra advises India deal

Abbot Laboratories’ Indian subsidiary, Abbott Capital, has offered to the shareholders of Solvay Pharma India Limited to acquire 20 percent of the voting capital, equal to about 10.1 lakh shares at Rs. 3,054.73 ($66.22) for each share.